In this week's Pharma Pulse, the EU Council adopts the "pharma package," Commerce details 0% tariffs for certain drugs and Sharp expands autoinjector assembly capacity.
|Articles|December 24, 2009
- Pharmaceutical Commerce - November/December 2009
Vetter Opens Injectables Packaging Facility in Illinois
Advertisement
The first expansion of Ravensburg, Germany’s Vetter Pharma outside its home country is a 24,000-sq.-ft developmental facility in Skokie, IL. Vetter will handle preclinical through Phase IIb projects for syringes, vials and cartridges; Phase III production would continue in Ravensburg. The site is expected to be operational by the end of 2010 and will employ up to 60 workers.
Articles in this issue
almost 17 years ago
J&J/McNeil widens a recall of contaminated Tylenolalmost 17 years ago
Impax Labs Enjoys the Fruits of Its IBM Cognos Investmentalmost 17 years ago
Short Takesalmost 17 years ago
Industry Tackles the New REMS Hurdlealmost 17 years ago
Pharma Gets a 'Just in Time' Speedup With the Switch to Digital Printingalmost 17 years ago
Cargo Theft Emerges as a New Biopharma Worryalmost 17 years ago
Getting Value From End-of-Life-Cycle Pharmaceuticalsalmost 17 years ago
HDMA Analyzes Evolving Specialty Distribution BusinessAdvertisement
Related to this article
In this week's Pharma Pulse, Vicapsys merges with Stateline, Veritiv targets GLP-1 shipping, Section 232 tariffs widen and HRSA's 340B rebate pilot deadline arrives.
McKesson's Chris Van Norman previews his LogiPharma USA keynote on demand signal sharing, AI, and precision distribution for targeted therapies.
LogiPharma's Charleen Ring and McKesson's Chris Van Norman preview the 2026 agenda, sessions to prioritize and a day two fireside chat.
Cardinal Health and McKesson moved to extend CVS Health distribution deals through June 2032, retaining their largest customer pending final contracts.
Inside the October 2026 issue: why splitting MMR takes years, why payers cite a price that does not bind them, and what pricing rules broke.
Mike Hennessy Jr. on the commercial assumptions being rewritten across pricing, patient engagement and supply chain in PC's October 2026 print issue.
In this Q&A, Doceree CEO Harshit Jain, MD, explains why AI should inform prescribing decisions, not drive them, and how sales reps own relationships while AI extends reach.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Cardinal Health, McKesson Extend CVS Distribution Deals to 2032
2
How Distribution Is Evolving for Today's Targeted Therapies
3
What to Watch at LogiPharma: Resilience, Practical AI and New Peer Formats
4
Your Patient Support Data Shows What Happened. Can It Tell You Why?
5